Nutrition21 Transitions to Applied DNA’s CertainT® Platform to Secure IP-protected Portfolio of Dietary Supplement Ingredi...
December 07 2020 - 8:00AM
Business Wire
- Applied DNA Receives Follow-On Orders -
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the
"Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA
manufacturing, today announced the expansion of commercial
activities under its multi-year Master Services Agreement (MSA)
with Nutrition21 whereby Nutrition21 has transitioned to Applied
DNA’s CertainT® platform to secure its IP-protected portfolio of
dietary supplement ingredients. Concurrently, the Company received
two follow-on orders for a second year of commercial production,
the majority of which is expected to be shipped in the current
fiscal quarter. The financial terms of the follow-on orders were
not disclosed.
Nutrition21, a trusted developer and supplier of novel and
clinically substantiated branded ingredients for the nutritional
supplement industry, is the first to adopt the platform to protect
the IP of its ingredients. Utilizing CertainT, Nutrition21 can
certify that its licensees use authentic ingredients and in the
proper amounts, and also identify IP infringement by non-licensees.
A SigNature® molecular tag is applied to Nutrition21 ingredients to
provide evidence of its product dosages in finished products
shipped to market. The molecular tag is supported by ongoing
quality control testing services for production and high-resolution
testing services for products audited in-market. Nutrition21 holds
over 100 domestic and international issued and pending patents for
its products.
“The expansion of CertainT’s application within Nutrition21 is
testament to our platform’s ability to support Nutrition21’s
dedication to ensuring confidence in its ingredients portfolio,”
said Dr. James A. Hayward, president and CEO, Applied DNA. “With
its diverse portfolio of patented health and wellness ingredients,
we believe we are in the early stages of an impactful commercial
relationship with Nutrition21 and, by proxy, the dietary
supplements industry.”
Joe Weiss, President of Nutrition21, stated, “After an
extensive search to replace our current marker technology, we have
now transitioned to the CertainT platform. Marketing partners and
customers of Nutrition21 can rest assured that we will utilize the
CertainT platform to protect them against infringers of our
intellectual property, and most importantly, assure consumers that
they are getting the Nutrition21 ingredients that are listed on
their product label.”
About CertainT
The CertainT® platform has three technology pillars (Tag, Test,
Track), which allows raw materials and products to be tagged with a
unique molecular identifier. This identifier can then be tested for
its presence as it travels throughout a global supply chain. All
the data points associated to tagging and testing are tracked by
uploading to a secure cloud database. The platform can be used
across industries such as textiles, cannabis, military, leather,
fertilizer, pharmaceuticals, personal care.
About Nutrition21, LLC
Nutrition21 is a trusted developer and supplier of novel and
clinically substantiated branded ingredients for the nutritional
supplement industry. With a diverse portfolio of patented health
and wellness ingredients, Nutrition21 provides ingredient solutions
to some of the most successful dietary supplement brands in the
marketplace today.
Nutrition21 currently holds over 100 domestic and international
issued and pending patents for products with highly marketable
claims including: Nitrosigine®, Velositol®, Chromax®, nooLVL®, and
Lepidamax®. Innovative Ingredients. Real Results
For more information, please visit: www.Nutrition21.com.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping, and pre-clinical nucleic acid-based
therapeutic drug candidates.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under ticker
symbol ‘APDN’, and its publicly traded warrants are listed on OTC
under ticker symbol ‘APPDW’.
Applied DNA is a member of the Russell Microcap® Index.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934 and the Private Securities Litigation Reform Act of
1995. Forward-looking statements describe Applied DNA’s future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to, its history of
net losses, limited financial resources, limited market acceptance,
the uncertainties inherent in research and development, our ability
to successfully enter into commercial contracts for the
implementation of our CertainT® platform, disruptions in the supply
of raw materials and supplies, and various other factors detailed
from time to time in Applied DNA’s SEC reports and filings,
including our Annual Report on Form 10-K filed on December 12, 2019
and our subsequent quarterly reports on Form 10-Q filed on February
6, 2020, May 14, 2020 and August 6, 2020, and other reports we file
with the SEC, which are available at www.sec.gov. Applied DNA
undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances
after the date hereof or to reflect the occurrence of unanticipated
events, unless otherwise required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201207005214/en/
Investor contact: Sanjay M. Hurry, Applied DNA Sciences,
917-733-5573, sanjay.hurry@adnas.com Program contact: Judy
Murrah, Applied DNA Sciences, 631-240-8819, judy.murrah@adnas.com
Web: www.adnas.com Twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024